Lead Quality Control Site Development
Bachem
Lead Quality Control Site Development
Bachem
Develops and manufactures peptides and oligonucleotides
The Bachem Group is investing in a new planned site in Sisslerfeld in Northwestern Switzerland. This step is part of the long-term strategy to expand production capacity by the end of the decade. The new production site will play a central role in achieving these goals. The design phase of the project offers you unique opportunities to shape the future organization.
As part of the development of our new Sisslerfeld manufacturing site, we are looking for a Lead QC Sisslerfeld Site Develepoment (a) 100%. In this key role, your focus will be to establish and lead the ramp-up of the Quality Control organization, driving the successful setup of laboratories, systems, and processes while ensuring regulatory compliance, operational readiness, and sustainable quality excellence.
Your tasks
Your profile
Our offer:
Would you like to shape global Operational Readiness frameworks with us?
We look forward to receiving your complete application documents via our application portal.
Learn more about the Bachem Group and our working environment at the Stein site on our website.
Bachem provides development and manufacturing of peptides and oligonucleotides for research, clinical development, and commercial products. Its offerings include custom synthesis and scale-up production, analytical testing, and related services across the drug development spectrum. Customers work with Bachem by specifying desired sequences and specifications, after which Bachem designs, synthesizes, and quality-controls the peptides or oligonucleotides and delivers them in appropriate scales and formats. The company differentiates itself through more than five decades of experience, a global footprint with sites in Europe, the US, and Asia, and an integrated set of services spanning discovery support to commercial manufacturing. Its goal is to help pharmaceutical and biotechnology companies advance peptide- and oligonucleotide-based therapies by providing reliable, scalable, and well-supported manufacturing and development capabilities.
Explore more opportunities at Bachem